source
- STAT+: Pharmalittle: We’re reading about a Supreme Court setback for pharma, TrumpRx expands and much moreThe latest pharmaceutical news from the Pharmalot campus via the Pharmalittle newsletterSTAT · 2mo ago↗ source
- Relay drug shows early promise against rare blood vessel diseasesWhile early, the findings suggest the therapy could be superior to Novartis’ Vijoice at treating “vascular anomalies,” a cluster of chronic conditions with few available treatments.BioPharma Dive · 2mo ago↗ source
- STAT+: Eli Lilly tops prominent rankings on pharma R&D performanceA new set of lists ranks drug company laboratories on two criteria: innovation and invention.STAT · 2mo ago↗ source